⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18756269 | 1.00 | — | — | |
| SCHEMBL28069239 | 1.00 | — | — | |
| SCHEMBL20047741 | 1.00 | — | — | |
| SCHEMBL13191760 | 1.00 | — | — | |
| SCHEMBL9611985 | 1.00 | — | — | |
| SCHEMBL16455186 | 1.00 | — | — | |
| SCHEMBL19852927 | 0.80 | — | — | |
| SCHEMBL16392571 | 0.80 | — | — | |
| SCHEMBL9013219 | 0.80 | — | — | |
| SCHEMBL20925405 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023242187-A1 | ENZYMATIC MODIFICATION OF SAPONINS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023066885-A1 | SAPONIN PRODUCTION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2022122830-A2 | SAPONINS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-06-16 | — | — | WO | disclosed |
| US-20120009131-A1 | METHOD FOR PREVENTING OR TREATING AMYLOID BETA PEPTIDE-ASSOCIATED DISEASES OR CONDITIONS, AND METHOD FOR INHIBITING FORMATION, ACCUMULATION OR AGGREGATION OF AMYLOID BETA PEPTIDES | SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD. (HANGZHOU) (CN) | 2012-01-12 | — | — | US | disclosed |